E-ISSN: 1308-5263
Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives [Turk J Hematol]
Turk J Hematol. 2019; 36(1): 53-54 | DOI: 10.4274/tjh.galenos.2018.2018.0397  

Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives

Won Sriwijitalai1, Viroj Wiwanitkit2
1TWS Medical Center, Bangkok, Thailand
2Dr. DY Patil University, Pune, India

Keywords: Bendamustine, Rituximab, Leukemia, Direct antiglobulin test, False negatives


Bendamustin ve Rituksimab Tedavisi, Kronik Lenfositik Lösemi, Direkt Antiglobulin Test ve Yanlış Negatiflik

Won Sriwijitalai1, Viroj Wiwanitkit2
1TWS Medical Center, Bangkok, Thailand
2Dr. DY Patil University, Pune, India

Anahtar Kelimeler: Bendamustin, Rituksimab, Lösemi, Direkt antiglobulin testi, Yanlış negatiflik


Won Sriwijitalai, Viroj Wiwanitkit. Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives. Turk J Hematol. 2019; 36(1): 53-54

Corresponding Author: Won Sriwijitalai, Thailand


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2017) = 0.650